Effect of coenzyme-Q10 on doxorubicin-induced nephrotoxicity in rats

Advances in Pharmacological Sciences

Volumn 2012, Issue , 2012, Pages

  El Sheikh, Azza A K ^a   Morsy, Mohamed A ^a   Mahmoud, Marwa M ^a   Rifaai, Rehab A ^a   Abdelrahman, Aly M ^a  

^a Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CATALASE; CREATININE; DOXORUBICIN; GLUTATHIONE; MALONALDEHYDE; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; ENZYME ACTIVITY; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

EID: 84872133100     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2012/981461     Document Type: Article

References (31)

1. Carvalho C., Santos R. X., Cardoso S., Correia S., Oliveira P. J., Santos M. S., Moreira P. I., Doxorubicin: the good, the bad and the ugly effect. Current Medicinal Chemistry 2009 16 25 3267 3285 2-s2.0-70450215499 10.2174/092986709788803312
2. Ghibu S., Delemasure S., Richard C., General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Biochimie 2011 94 4 932 939
3. Mizutani H., Tada-Oikawa S., Hiraku Y., Kojima M., Kawanishi S., Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sciences 2005 76 13 1439 1453 2-s2.0-12844275026 10.1016/j.lfs.2004.05.040 (Pubitemid 40164773)
4. Lee V. W., Harris D. C., Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology 2011 16 1 30 38 2-s2.0-78650643890 10.1111/j.1440-1797.2010.01383.x
5. Granados-Principal S., Quiles J. L., Ramirez-Tortosa C. L., Sanchez-Rovira P., Ramirez-Tortosa M., New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food and Chemical Toxicology 2010 48 6 1425 1438 2-s2.0-77952876927 10.1016/j.fct.2010. 04.007
6. Conklin K. A., Coenzyme Q10 for prevention of anthracycline-induced cardiotoxicity. Integrative Cancer Therapies 2005 4 2 110 130 2-s2.0-19544371393 10.1177/1534735405276191 (Pubitemid 40731561)
7. Littarru G. P., Tiano L., Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular Biotechnology 2007 37 1 31 37 2-s2.0-35848963373 10.1007/s12033-007-0052-y (Pubitemid 350135901)
8. Pravst I., Žmitek K., Žmitek J., Coenzyme Q10 contents in foods and fortification strategies. Critical Reviews in Food Science and Nutrition 2010 50 4 269 280 2-s2.0-77949562391 10.1080/10408390902773037
9. Villalba J. M., Parrado C., Santos-Gonzalez M., Alcain F. J., Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opinion on Investigational Drugs 2010 19 4 535 554 2-s2.0-77952518304 10.1517/13543781003727495
10. Fouad A. A., Al-Sultan A. I., Refaie S. M., Yacoubi M. T., Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 2010 274 1-3 49 56 2-s2.0-77954141949 10.1016/j.tox.2010.05.007
11. Persson M. F., Franzen S., Catrina S. B., Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 2012 55 5 1535 1543
12. Sutken E., Aral E., Ozdemir F., Uslu S., Alatas O., Colak O., Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney. International Journal of Toxicology 2007 26 1 81 87 2-s2.0-33847665561 10.1080/10915810601122893 (Pubitemid 46360920)
13. Długosz A., Kuźniar J., Sawicka E., Marchewka Z., Lembas-Bogaczyk J., Sajewicz W., Boratyńska M., Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients. International Urology and Nephrology 2004 36 2 253 258 2-s2.0-17044448658 10.1023/B:UROL. 0000034652.88578.a8 (Pubitemid 38961785)
14. El-Abhar H. S., Coenzyme Q10: a novel gastroprotective effect via modulation of vascular permeability, prostaglandin E2, nitric oxide and redox status in indomethacin-induced gastric ulcer model. European Journal of Pharmacology 2010 649 1-3 314 319 2-s2.0-78049283800 10.1016/j.ejphar.2010.09. 012
15. Ajith T. A., Aswathy M. S., Hema U., Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity. Food and Chemical Toxicology 2008 46 9 3178 3181 2-s2.0-50249105186 10.1016/j.fct.2008.07.004
16. Buege J. A., Aust S. D., Microsomal lipid peroxidation. Methods in Enzymology 1978 52 302 310 2-s2.0-0017872475 10.1016/S0076-6879(78)52032-6
17. Sastry K. V. H., Moudgal R. P., Mohan J., Tyagi J. S., Rao G. S., Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Analytical Biochemistry 2002 306 1 79 82 2-s2.0-0036629201 10.1006/abio.2002.5676 (Pubitemid 34722019)
18. Eaton S., Skinner R., Hale J. P., Pourfarzam M., Roberts A., Price L., Bartlett K., Plasma coenzyme Q10 in children and adolescents undergoing doxorubicin therapy. Clinica Chimica Acta 2000 302 1-2 1 9 2-s2.0-0033768641 10.1016/S0009-8981(00)00316-8
19. Brea-Calvo G., Rodríguez-Hernández A., Fernández- Ayala D. J., Navas P., Sánchez-Alcázar J. A., Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines. Free Radical Biology & Medicine 2006 40 8 1293 1302
20. Chabner B. A., Ryan D. P., Paz-Ares L., Garcia-Carbonevo R., Calabresi P., Hardman J. G., Limbird L. E., Gilman A. G., Antineoplastic agents. Goodman and Gilman's the Pharmacological Basis of Therapeutics 2001 New York, NY, USA McGraw-Hill 1389 1459
21. Yagmurca M., Erdogan H., Iraz M., Songur A., Ucar M., Fadillioglu E., Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clinica Chimica Acta 2004 348 1-2 27 34 2-s2.0-4444337991 10.1016/j.cccn.2004.03.035 (Pubitemid 39208997)
22. Mohan M., Kamble S., Gadhi P., Kasture S., Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food and Chemical Toxicology 2010 48 1 436 440 2-s2.0-72449128132 10.1016/j.fct.2009.10.042
23. Zhou Q., Chowbay B., Effect of coenzyme Q10 on the disposition of doxorubicin in rats. European Journal of Drug Metabolism and Pharmacokinetics 2002 27 3 185 192 2-s2.0-0036629515
24. Greenlee H., Shaw J., Lau Y. K., Naini A., Maurer M., Lack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures. Integrative Cancer Therapies 2012 11 3 243 250
25. Sahu S. C., Gray G. C., Pro-oxidant activity of flavanoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Letters 1996 104 2 193 196 2-s2.0-0030010582 10.1016/0304-3835(96)04251-6
26. Tanwar V., Sachdeva J., Golechha M., Kumari S., Arya D. S., Curcumin protects rat myocardium against isoproterenol-induced ischemic injury: attenuation of ventricular dysfunction through increased expression of hsp27 alongwith strengthening antioxidant defense system. Journal of Cardiovascular Pharmacology 2010 55 4 377 384 2-s2.0-77951711190 10.1097/FJC.0b013e3181d3da01
27. Beyer R. E., The participation of coenzyme Q in free radical production and antioxidation. Free Radical Biology and Medicine 1990 8 6 545 565 2-s2.0-0025286523 10.1016/0891-5849(90)90154-B (Pubitemid 20204419)
28. Beyer R. E., An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochemistry and Cell Biology 1992 70 6 390 403 2-s2.0-0026879664
29. Linnane A. W., Kios M., Vitetta L., Coenzyme Q10-Its role as a prooxidant in the formation of superoxide anion/hydrogen peroxide and the regulation of the metabolome. Mitochondrion 2007 7 S51 S61 2-s2.0-34248184025 10.1016/j.mito.2007.03.005 (Pubitemid 46712233)
30. Plecitá-Hlavatá L., Ježek J., Ježek P., Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I. International Journal of Biochemistry and Cell Biology 2009 41 8-9 1697 1707 2-s2.0-67349139588 10.1016/j.biocel.2009.02.015
31. Sakata T., Furuya R., Shimazu T., Odamaki M., Ohkawa S., Kumagai H., Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients. Blood Purification 2008 26 4 371 378 2-s2.0-48349147500 10.1159/000135605